发布求助
文献互助 智能选刊 最新文献

PharmacoEconomics Spanish Research Articles最新文献

筛选
英文 中文
Estudio de impacto presupuestario y coste-efectividad de la introducción de LacTEST en el diagnóstico de la hipolactasia en España 在西班牙引入LacTEST诊断低脂症的预算影响和成本效益研究
PharmacoEconomics Spanish Research Articles Pub Date : 2014-12-01 DOI: 10.1007/S40277-013-0025-4
J. Darbá, Lisette Kaskens, A. Gracia
{"title":"Estudio de impacto presupuestario y coste-efectividad de la introducción de LacTEST en el diagnóstico de la hipolactasia en España","authors":"J. Darbá, Lisette Kaskens, A. Gracia","doi":"10.1007/S40277-013-0025-4","DOIUrl":"https://doi.org/10.1007/S40277-013-0025-4","url":null,"abstract":"","PeriodicalId":101511,"journal":{"name":"PharmacoEconomics Spanish Research Articles","volume":"67 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2014-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124550591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Tratamiento biológico de la artritis reumatoide en España. Análisis de impacto presupuestario de la utilización de certolizumab pegol 西班牙类风湿性关节炎的生物治疗。使用certolizumab pegol的预算影响分析
PharmacoEconomics Spanish Research Articles Pub Date : 2014-09-01 DOI: 10.1007/S40277-013-0019-2
Álvaro Hidalgo, R. Villoro, Alexandra Ivanova, Alberto Morell, P. Talavera, Belén Ferro
{"title":"Tratamiento biológico de la artritis reumatoide en España. Análisis de impacto presupuestario de la utilización de certolizumab pegol","authors":"Álvaro Hidalgo, R. Villoro, Alexandra Ivanova, Alberto Morell, P. Talavera, Belén Ferro","doi":"10.1007/S40277-013-0019-2","DOIUrl":"https://doi.org/10.1007/S40277-013-0019-2","url":null,"abstract":"","PeriodicalId":101511,"journal":{"name":"PharmacoEconomics Spanish Research Articles","volume":"117 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2014-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122325578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Análisis de patrones de tratamiento y coste farmacológico en pacientes con cáncer colorrectal metastásico en un hospital general 综合医院转移性结直肠癌患者的治疗模式和药理成本分析
PharmacoEconomics Spanish Research Articles Pub Date : 2014-09-01 DOI: 10.1007/S40277-013-0017-4
Covadonga Torres, I. Oyagüez, V. Lozano, C. Pericay, Montserrat Pàmpols, M. Casado
{"title":"Análisis de patrones de tratamiento y coste farmacológico en pacientes con cáncer colorrectal metastásico en un hospital general","authors":"Covadonga Torres, I. Oyagüez, V. Lozano, C. Pericay, Montserrat Pàmpols, M. Casado","doi":"10.1007/S40277-013-0017-4","DOIUrl":"https://doi.org/10.1007/S40277-013-0017-4","url":null,"abstract":"","PeriodicalId":101511,"journal":{"name":"PharmacoEconomics Spanish Research Articles","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2014-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122696546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Coste-efectividad de dasatinib frente a dosis altas de imatinib y nilotinib en pacientes con leucemia mieloide crónica resistente a la dosis estándar de imatinib en Portugal 葡萄牙标准剂量伊马替尼耐药慢性髓系白血病患者达沙替尼与高剂量伊马替尼和尼洛替尼的成本效益
PharmacoEconomics Spanish Research Articles Pub Date : 2014-09-01 DOI: 10.1007/S40277-013-0027-2
J. Darbá, Lisette Kaskens, Manuel Abecassis, J. Carrasco, Ricardo Vitorino, Matthew J. Taylor
{"title":"Coste-efectividad de dasatinib frente a dosis altas de imatinib y nilotinib en pacientes con leucemia mieloide crónica resistente a la dosis estándar de imatinib en Portugal","authors":"J. Darbá, Lisette Kaskens, Manuel Abecassis, J. Carrasco, Ricardo Vitorino, Matthew J. Taylor","doi":"10.1007/S40277-013-0027-2","DOIUrl":"https://doi.org/10.1007/S40277-013-0027-2","url":null,"abstract":"","PeriodicalId":101511,"journal":{"name":"PharmacoEconomics Spanish Research Articles","volume":"47 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2014-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115837413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Análisis de impacto presupuestario del uso de fentanilo intranasal en pectina para el tratamiento del dolor irruptivo oncológico 果胶中鼻内芬太尼治疗肿瘤突发性疼痛的预算影响分析
PharmacoEconomics Spanish Research Articles Pub Date : 2014-06-01 DOI: 10.1007/S40277-013-0018-3
Rafael López, J. J. Cruz, R. Gálvez, Y. Escobar, J. Juliá, A. Mañas, Francisco Zaragozá, C. Margarit, A. Casas, Antonio Antón, Y. Riesgo
{"title":"Análisis de impacto presupuestario del uso de fentanilo intranasal en pectina para el tratamiento del dolor irruptivo oncológico","authors":"Rafael López, J. J. Cruz, R. Gálvez, Y. Escobar, J. Juliá, A. Mañas, Francisco Zaragozá, C. Margarit, A. Casas, Antonio Antón, Y. Riesgo","doi":"10.1007/S40277-013-0018-3","DOIUrl":"https://doi.org/10.1007/S40277-013-0018-3","url":null,"abstract":"","PeriodicalId":101511,"journal":{"name":"PharmacoEconomics Spanish Research Articles","volume":"9 4","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2014-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114116328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Evaluación de las consecuencias socioeconómicas de la progresión de la enfermedad de Alzheimer en pacientes con demencia y deterioro cognitivo. Análisis exploratorio de la valoración de la eficacia de cinco medidas clínicas 评估阿尔茨海默病进展对痴呆和认知障碍患者的社会经济后果。对五种临床措施有效性评价的探索性分析
PharmacoEconomics Spanish Research Articles Pub Date : 2014-06-01 DOI: 10.1007/S40277-013-0026-3
J. Darbá, Lisette Kaskens, Loretto Lacey, Albert Lleo, Peter J. Anderson
{"title":"Evaluación de las consecuencias socioeconómicas de la progresión de la enfermedad de Alzheimer en pacientes con demencia y deterioro cognitivo. Análisis exploratorio de la valoración de la eficacia de cinco medidas clínicas","authors":"J. Darbá, Lisette Kaskens, Loretto Lacey, Albert Lleo, Peter J. Anderson","doi":"10.1007/S40277-013-0026-3","DOIUrl":"https://doi.org/10.1007/S40277-013-0026-3","url":null,"abstract":"","PeriodicalId":101511,"journal":{"name":"PharmacoEconomics Spanish Research Articles","volume":"26 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2014-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124372713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Costes de los agentes estimulantes de la eritropoyesis en el tratamiento de la anemia inducida por quimioterapia en España: resultados preliminares procedentes de la adaptación de un estudio belga 西班牙化疗引起的贫血治疗中促红细胞生成剂的成本:比利时一项研究的初步结果
PharmacoEconomics Spanish Research Articles Pub Date : 2014-03-01 DOI: 10.1007/S40277-013-0022-7
Á. Durán, Erik Spaepen, M. Lamotte, M. Brosa, Laura Gutiérrez, G. Restovic
{"title":"Costes de los agentes estimulantes de la eritropoyesis en el tratamiento de la anemia inducida por quimioterapia en España: resultados preliminares procedentes de la adaptación de un estudio belga","authors":"Á. Durán, Erik Spaepen, M. Lamotte, M. Brosa, Laura Gutiérrez, G. Restovic","doi":"10.1007/S40277-013-0022-7","DOIUrl":"https://doi.org/10.1007/S40277-013-0022-7","url":null,"abstract":"","PeriodicalId":101511,"journal":{"name":"PharmacoEconomics Spanish Research Articles","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2014-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123380723","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Análisis del impacto presupuestario tras la comercialización de nilotinib en el tratamiento de primera línea en pacientes con leucemia mieloide crónica de nuevo diagnóstico en España 分析尼洛替尼在西班牙新诊断的慢性髓系白血病一线治疗中商业化后的预算影响
PharmacoEconomics Spanish Research Articles Pub Date : 2014-01-18 DOI: 10.1007/S40277-013-0004-9
Emmanuel Giménez García, M. Portero, Concepción Boqué, Asunción Echeveste, R. Paz, S. Castillo, R. Calzada, J. González, V. García-Gutiérrez
{"title":"Análisis del impacto presupuestario tras la comercialización de nilotinib en el tratamiento de primera línea en pacientes con leucemia mieloide crónica de nuevo diagnóstico en España","authors":"Emmanuel Giménez García, M. Portero, Concepción Boqué, Asunción Echeveste, R. Paz, S. Castillo, R. Calzada, J. González, V. García-Gutiérrez","doi":"10.1007/S40277-013-0004-9","DOIUrl":"https://doi.org/10.1007/S40277-013-0004-9","url":null,"abstract":"","PeriodicalId":101511,"journal":{"name":"PharmacoEconomics Spanish Research Articles","volume":"59 4 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2014-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124320861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluación económica del uso de duloxetina en el tratamiento del dolor crónico causado por osteoartritis de rodilla en el sistema privado de salud en México 度洛西汀在墨西哥私人卫生系统中治疗膝关节骨关节炎引起的慢性疼痛的经济评价
PharmacoEconomics Spanish Research Articles Pub Date : 2014-01-08 DOI: 10.1007/S40277-013-0028-1
Miguel Elizondo-Cano, Fernando Carlos-Rivera, Jocelyn Ramírez-Gámez, H. Dueñas
{"title":"Evaluación económica del uso de duloxetina en el tratamiento del dolor crónico causado por osteoartritis de rodilla en el sistema privado de salud en México","authors":"Miguel Elizondo-Cano, Fernando Carlos-Rivera, Jocelyn Ramírez-Gámez, H. Dueñas","doi":"10.1007/S40277-013-0028-1","DOIUrl":"https://doi.org/10.1007/S40277-013-0028-1","url":null,"abstract":"","PeriodicalId":101511,"journal":{"name":"PharmacoEconomics Spanish Research Articles","volume":"11 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2014-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130649636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Estudio de los costes del desarrollo de inhibidores en pacientes con hemofilia A grave en España 西班牙A型血友病患者抑制剂开发成本的研究
PharmacoEconomics Spanish Research Articles Pub Date : 2013-05-17 DOI: 10.1007/S40277-013-0016-5
José Antonio Romero Garrido, José Félix Lucía Cuesta, Laia Febrer, I. Trabal, F. J. Sabater, L. Lindner, A. Herrero
{"title":"Estudio de los costes del desarrollo de inhibidores en pacientes con hemofilia A grave en España","authors":"José Antonio Romero Garrido, José Félix Lucía Cuesta, Laia Febrer, I. Trabal, F. J. Sabater, L. Lindner, A. Herrero","doi":"10.1007/S40277-013-0016-5","DOIUrl":"https://doi.org/10.1007/S40277-013-0016-5","url":null,"abstract":"","PeriodicalId":101511,"journal":{"name":"PharmacoEconomics Spanish Research Articles","volume":"156 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2013-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130661806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信